Telmisartan — Drug Intelligence | 5 EU Trials

Filter these 5 trials by condition, phase, country and more.

5 Registered trials

2 Recruiting

3 Completed trials

5 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 3

Oversight events:

1 serious breach across 1 trial

Indications tested

5 total

TECA study Recruiting

2024-513351-33-00 Phase II 1 country Medical University Of Vienna
Continuing Anticoagulants and Antiplatelets in Cold snare Polypectomy. Recruiting

2024-511265-11-01 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria Aragon
Efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis Ended

2023-504597-37-00 Phase III 7 countries Dimerix Bioscience Pty Limited
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Phase IV 1 country Spanish Society Of Cardiology
GENPAD Ended

2024-518122-33-00 Phase IV 1 country Radboud universitair medisch centrum Stichting

Showing 1–5 of 5 trials